DEXTER SUSAN (Chief Technical Officer) received a stock award from SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2023ACC: 0001493152-23-005468
Officer· Chief Technical Officer
Since Apr 2020
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
14.63K acquired · 14.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−14.63K
Price / share
—
Trade value
—
% of position
61.8%
1/7/2023
23.67K→9.04K
Common Stock
Direct
Shares
+14.63K
Price / share
—
Trade value
—
% of position
161.8%
1/7/2023
9.04K→23.67K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2023 | D · Disposition | −14.63K | — | — | 61.8% | 23.67K | 9.04K |
| Common Stock Direct | 1/7/2023 | A · Award | +14.63K | — | — | 161.8% | 9.04K | 23.67K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported